These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 9617575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression and function of members of the cytokine receptor superfamily on breast cancer cells.
    Douglas AM, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA, Begley CG.
    Oncogene; 1997 Feb 13; 14(6):661-9. PubMed ID: 9038373
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.
    J Pathol; 2004 Jan 13; 202(1):41-9. PubMed ID: 14694520
    [Abstract] [Full Text] [Related]

  • 8. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S, Murakami-Mori K, Bonavida B.
    Anticancer Res; 1999 Jan 13; 19(2A):1011-5. PubMed ID: 10368647
    [Abstract] [Full Text] [Related]

  • 9. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP, Bruce AG.
    New Biol; 1992 Jan 13; 4(1):61-5. PubMed ID: 1536831
    [Abstract] [Full Text] [Related]

  • 10. Are LIF and related cytokines functionally equivalent?
    Piquet-Pellorce C, Grey L, Mereau A, Heath JK.
    Exp Cell Res; 1994 Aug 13; 213(2):340-7. PubMed ID: 8050491
    [Abstract] [Full Text] [Related]

  • 11. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM, Campbell CL, McQuain C, Mitchell K, Guardiani R, Quesenberry PJ, Nelson BE.
    Cytokine; 2002 Mar 21; 17(6):324-34. PubMed ID: 12061840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N, Heath JK.
    Cancer Res; 2006 Nov 15; 66(22):10891-901. PubMed ID: 17108126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG.
    Oncogene; 2002 Jan 17; 21(3):460-74. PubMed ID: 11821958
    [Abstract] [Full Text] [Related]

  • 20. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
    Terada S, Suzuki E, Ueda H, Makishima F.
    Cytokine; 1996 Dec 17; 8(12):889-94. PubMed ID: 9050746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.